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Affinity purified, detergent-solubilised porcine TSH receptors have been crosslinked to a 12SI-labelled photo- 
active derivative of TSH and analysed by gel electrophoresis, gel filtration and sucrose density gradient centri- 
fugation. Our studies suggest that the porcine TSH receptor is made up of a hydrophilic A subunit with 
an M,of about 45000 linked to an amphiphilic B subunit (M,approx. 25000) by a disulphide bridge(s). 
The A subunit forms the binding site for TSH on the outside of the cell membrane. The B subunit appears 
to penetrate the membrane and form the site for interaction with adenylate cyclase either in the lipid bilayer 
or close to the cytoplasmic surface of the membrane. 
Thyrotropin Receptor Thyroid Graves ’ disease Aj$nity labelling Crosslinking 
1. INTRODUCTION 
Recent studies have shown that the TSH recep- 
tor can be covalently crosslinked to ‘251-labelled 
TSH and the crosslinked complex used to 
characterise the receptor [ 1,2]. We now describe an 
analysis of the porcine TSH receptor using this ap- 
proach in combination with polyacrylamide gel 
electrophoresis in SDS (SDS-PAGE), sucrose den- 
sity gradient centrifugation and gel filtration. Our 
studies suggest that the porcine TSH receptor is 
made up of a hydrophilic A-subunit with Mr of 
about 45000 linked to an amphiphilic B-subunit 
(MI approx. 25000) by a disulphide bridge(s). The 
A-subunit forms the binding site for TSH on the 
outside of the cell membrane. The B-subunit ap- 
pears to penetrate the membrane and form the site 
for interaction with adenylate cyclase either in the 
lipid bilayer or close to the cytoplasmic surface of 
the membrane. 
2. MATERIALS AND METHODS 
2.1. Preparation and SDS-PAGE analysis of 
crosslin ked TSH- TSH receptor complexes 
Highly purified bovine TSH (70 units per mg) 
was coupled to the photoactive crosslinking 
reagent N-hydroxysuccinimidyl-4-azidobenzoate 
(HSAB) and labelled with “‘1 [1,2]. This material 
contained similar amounts of “‘1 and HSAB on 
each subunit of TSH [ 1,2]. 
Affinity purified Lubrol solubilised [3] porcine 
TSH receptors (5 ml) were incubated in the dark 
for 3 h at room temperature with 5 ml (200 ,Ki) of 
‘251-1abelled HSAB-TSH, photolysed (254 nm; 
20 min) and run at 2-4°C on a 250-ml column of 
Sephacryl S-300 in 50 mM NaCl; 10 mM 
Tris-HCl, pH 7.5 (Tris-NaCl) containing 0.1% 
Lubrol 12A9 (ICI Organics Division) to remove 
free TSH and small amounts of aggregate [7]. For- 
mation of the complex was completely inhibited by 
an excess (100 mu) of unlabelled TSH. 
The partially purified crosslinked TSH-TSH 
receptor complex was stored at 0°C for up to 4 
weeks. Most of the ‘251-HSAB-TSH was cross- 
linked to the receptor as shown by the relatively 
small amount of free ‘251-HSAB-TSH observed on 
SDS-PAGE (fig. 1). Furthermore, when the 
crosslinked complex was rerun on the S-300 col- 
umn in the presence of 100 mU of unlabelled TSH 
only 10% of the eluted radioactivity corresponded 
to free 1251-HSAB-TSH. 
SDS-PAGE and autoradiography were carried 
out as in [1,2] using 8-12% gradient gels and a 
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water-cooled Biorad apparatus. In some cases 
10 mM DTT (final concentration) was used to 
reduce the crosslinked complexes prior to elec- 
trophoresis. Warming of samples in SDS prior to 
electrophoresis caused dissociation of TSH 
subunits and a more complex pattern [1,2] on the 
gels. Consequently, care was taken to apply 
samples to the gel immediately after preparation. 
This resulted in more precise M, determinations 
than reported previously [ 11. 
2.2. Analysis of crosslinked TSH-TSH receptor 
complexes by sucrose density gradient 
centrifugation 
Crosslinked complexes (l-ml aliquots) were run 
(150 min; 300000 x g; 4°C) on linear sucrose gra- 
dients (5-20%, w/v; 17 ml) using a vertical rotor. 
Marker proteins were analysed under the same 
conditions in the same run. After each run, tubes 
were emptied from the bottom and fractions of 
about 0.5 ml were collected into tubes of known 
weight. After monitoring for “‘1 the fractions 
were weighed, absorbance at 280 nm and refrac- 
tive index determined and fraction volume 
calculated. 
2.3. Release of the TSH receptor A-subunit 
crosslinked to labelled TSH from thyroid 
membranes by treatment with DTT 
A crude membrane preparation was obtained 
from 5 g porcine thyroid tissue by differential cen- 
trifugation [3,7] and suspended in 5 ml of 
Tris-NaCl. Aliquots (500~1) were incubated with 
unlabelled TSH (10~1; O-O.5 units) for 15 min at 
20°C followed by L251-labelled HSAB-TSH 
(500~1) for 1 h at 37°C. After photolysis (254 nm 
for 20 min) and centrifugation (5 min; 14000 x g; 
4°C) the membranes were washed 3 times with 
Tris-NaCl (1 ml). The final pellets were 
resuspended in 100 ~1 of Tris-NaCl or Tris-NaC1 
containing 10 mM DTT. After incubation for 1 h 
at room temperature, the suspensions were cen- 
trifuged (100000 x g; 1 h; 4°C) and the super- 
natants analysed by SDS-PAGE or gel filtration 
on Sephacryl S-300 (250 ml) in Tris-NaCl without 
Lubrol. 
3. RESULTS AND DISCUSSION 
Analysis by SDS-PAGE showed that under 
non-reducing conditions, the crosslinked 
TSH-TSH receptor complex had an M, of about 
100000 and after subtraction of 28000 for the Mr 
of TSH [4] this suggested that the receptor itself 
had an M, of about 70000. After mild reduction 
however, the Mr of the crosslinked complex was 
about 73 000 giving an Mr for the reduced receptor 
of about 45000. Consequently, mild reduction 
resulted in the loss from the receptor of a subunit 
of I’@ approx. 25000 which was not crosslinked to 
TSH. These results suggested that the TSH recep- 
tor contained 2 subunits linked by a disulphide 
bridge(s). One subunit (defined as the A-subunit) 
had an M, of about 45000 and was crosslinked to 
TSH, the other (defined as the B-subunit) had an 
M, of about 25000 and was not crosslinked to 
TSH. 
Gels run under non-reducing conditions showed 
the presence of some aggregate material (which did 
not penetrate the gradient gel) and a diffuse 
background at higher M, (fig. 1). These effects were 
markedly less in reduced samples but there was 
some evidence of a small amount of incompletely 
reduced crosslinked complex at about 100 K and 
TSH subunits at low Mr. The diffuse background 
may have been due to ‘251-HSAB-TSH crosslinked 
non-specifically to lipid or detergent. 
Other subunits of the receptor, not crosslinked 
to TSH, may have been associated non-covalently 
with the A- or B-subunits but these were not evi- 
dent when additional crosslinking was attempted 
by adding disuccinimidyl suberate (DSS; 0.5 and 
1 mM final concentration) to affinity purified por- 
cine TSH receptors crosslinked to “‘1-HSAB-TSH 
(not shown). However, it was possible that any ad- 
ditional subunits were not accessible to crosslink- 
ing with DSS. 
When the partially purified crosslinked com- 
plexes were analysed in 0.1% Lubrol by sucrose 
density gradient centrifugation (fig.2) the 
crosslinked material sedimented at a rate slightly 
slower than catalase (11 S; M, 240000) suggesting 
a structure considerably larger than the M, of 
about 100000 observed on SDS gels (fig.1). 
However, the association of a large Lubrol micelle 
(Mr approx. 100000) [5] with the receptor during 
centrifugation would account for the apparent 
discrepancy. 
Treatment of crosslinked complexes with 
10 mM dithiothreitol (DTT) prior to centrifuga- 
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Fig. 1. Analysis of crosslinked TSH-TSH receptor 
complex by SDS-PAGE (see text for experimentai 
details). 
tion, caused a marked change in sedimentation 
characteristics with most of the radioactivity run- 
ning between TSH and BSA (fig.2). This suggested 
that after mild reduction, labelled TSH was prin- 
cipally associated with a much smaller structure; 
possibly due to the loss of the B-subunit from the 
receptor together with the LubroI micelle. 
To investigate this possibility further, analyses 
were carried out using a calibrated column 
(250 ml) of Sephacryl S-300 run in 0.1% Lubrol. 
Non-reduced complexes were eluted as a sym- 
metrical peak (ICar = 0.14) [6,7] together with a 
small amount of free TSH (I& = 0.50). Compiexes 
Complex reduced w~lh IOmM DTT ~. 
F 12000 
5 
f 10000 
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a 
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Fig.2. Analysis of crosslinked TSH-TSH receptor 
complex by sucrose density gradient centrifugation (see 
text for experimental data). 
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Fig.3. Proposed structure of the porcine TSH receptor. 
Currently, our studies do not provide an indication as to 
whether the B-subunit merely penetrates the lipid bilayer 
or spans the membrane to form a functionalIy important 
site at its cytoplasmic surface. The exact rofe of the 2 
subunits of TSH in forming the hormone’s receptor 
binding site is not known at present except that 
confirmational and/or structural contributions are 
required from both subunits (131. Previous tudies have 
suggested that the disulphide bridge(s) joining the A- 
and B-subunits is close to one end of the A-subunit f2]. 
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reduced in 10 mM DTT prior to chromatography, 
however, showed a different elution profile with 
the appearance of a major peak & = 0.32) 
eluting in a position between the non-reduced com- 
plex and TSH. Analysis of this K,, = 0.32 peak on 
SDS-PAGE showed it to be the A-subunit of the 
receptor crosslinked to intact TSH (M, = 73000). 
Conversion of the A-subunit crosslinked to 1251- 
HSAB-TSH from the K,, = 0.14 form to K,, = 
0.32 by mild reduction appeared to be almost com- 
plete as SDS-PAGE of the residual high-Mr 
radioactive material eluting from the column only 
showed the presence of small amounts of 12?- 
HSAB-TSH and a diffuse background at higher iW, 
(not shown). Similarly, most of the crosslinked 
complex was converted to slowly sedimenting 
material on sucrose density gradients after reduc- 
tion (fig.2). 
To determine whether the A-subunit of the 
receptor crosslinked to TSH (KaV = 0.32 peak) was 
associated with Lubrol micelles or not, Lubrol 
micelles were labelled with [3H]oleic acid ([3H]oleic 
acid is spontaneously incorporated into Lubrol 
micelles) and run on the S-300 column. The 
S-300 fractions 
70K+ 
50K+ 
28K+ 
23K- 
70K 
50K 
28K 
23K 
Fig.4. Release of the TSH receptor A-subunit crosslinked to labelled TSH from thyroid membranes by treatment with 
DTT (see text for experimental details). (a) SDS-PAGE. Lane 1, membranes crosslinked to labelled TSH and treated 
with Tris-NaCl. Lane 2, membranes crosslinked to labelled TSH and treated with Tris-NaC1 containing 10 mM DTT. 
Lane 3, membranes preincubated with 1 mU unlabelled TSH, crosslinked to labelled TSH and treated with Tris-NaCl 
containing 10 mM DTT. Lane 4, membranes preincubated with 10 mU unlabelled TSH, crosslinked to labelled TSH 
and treated with Tris-NaCl containing 10 mM DTT. Lane 5, reduced ‘251-labelled IgG. The crosslinked labelled 
TSH-TSH receptor A-subunit complex is the band with M, = 73000. The material in each of lanes l-4 was derived 
from the same amount of thyroid membranes (500 ~1) and ‘Z51-labe11ed HSAB-TSH (500 ~1). (b) Chromatography on 
Sephacryl S-300 in Tris-NaCl (i.e., in the absence of detergent) of material prepared as for lane 2 in panel a followed 
by SDS-PAGE. I, Void volume peak. II, Material eluting between void volume peak and peak III. III, Peak with K,, = 
0.35. IV, Peak with K,, = 0.55. 
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micelles eluted from the column in a single sym- 
metrical peak with K,, = 0.275 indicating that the 
micelles had a considerably larger Stokes radius 
than the TSH-TSH receptor A-subunit complex 
and consequently, the TSH-TSH receptor A- 
subunit complex could not have been associated 
with a Lubrol micelle during chromatography. 
This suggested that the A-subunit of the receptor 
was a hydrophilic peptide. As the intact receptor 
was associated with a Lubrol micelle these observa- 
tions suggest that the micelle was associated with 
the B-subunit of the receptor. 
If this suggestion is correct the region of the B- 
subunit which bound to the Lubrol micelle would 
be expected to penetrate the cell membrane prior to 
detergent solubilisation and the data suggest a 
possible structure for the receptor corresponding 
to that shown in fig.3. If this model is correct it 
should be possible to release the TSH receptor A- 
subunit crosslinked to TSH from thyroid mem- 
brane preparations merely by addition of reducing 
agent. This effect could be demonstrated as shown 
in fig.4a. The proportion of TSH receptor A- 
subunit crosslinked to ‘251-HSAB-TSH released 
from the membranes by DTT treatment was dif- 
ficult to estimate principally because of the need to 
use an excess of iz51-HSAB-TSH in the binding 
studies to provide sufficient counts in the 
crossiinked complex for visualisation on the gels. 
However, previous studies have shown that in- 
cubation of membrane-bound or detergent- 
solubilised TSH receptors with 5 mM DTT com- 
pletely inactivated the receptor in terms of TSH 
binding [8]. 
The material released by DTT treatment of 
thyroid membranes crosslinked to ‘251-HSAB-TSH 
was also run on the Sephacryl S-300 column after 
the column had been equilibrated with aqueous 
buffer (Tris-NaCl). Under these conditions, the 
A-subunit crosslinked to ‘251-HSAB-TSH eluted 
with a KaV of 0.35 (fig.4b) confirming the 
hydrophilic nature of the A-subunit and providing 
further evidence for the structure proposed in 
fig.3. 
Several comments concerning the proposed 
structure are appropriate: (i) There is a 
resemblance to the structure of the major 
histo~ompatibility antigens [9J; (ii) preIiminary 
studies with TSH receptor preparations from dif- 
ferent species suggest that their structures are 
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simifar with small differences in subunit Mr values 
between species [1,2]; (iii) freezing and thawing of 
human thyroid homogenates releases a water solu- 
ble component of the TSH receptor which contains 
binding sites for both TSH and TSH receptor an- 
tibodies [lo, 111. This component is probably close- 
ly related to the A-subunit of the receptor; (iv) the 
ability of the A- and B-subunits to dissociate readi- 
ly after reduction of their interchain disulphide 
bridges indicates that interchain non-covalent in- 
teractions in the crosslinked complex are of 
relatively low affinity; (v) the association of the B- 
subunit with the cell membrane suggests that it is 
this subunit which is involved in interaction with 
the regulatory subunits of adenylate cyclase [12]. 
These interactions may occur inside the lipid 
bilayer or at the cytoplasmic surface of the 
membrane. 
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